NCT06027671

Brief Summary

The overarching goal of this study is to implement a transition community adherence club strategy (Full-SPARCS) for HIV-positive individuals transitioning from correctional to community settings in South Africa. The investigators seek to provide actionable findings to inform policy decisions to contribute to HIV care continuity with this population. The investigators note that effectiveness and scalability often conflict with intervention design; thus, the investigators have proposed testing whether a group approach is effective and the investigators will assess the costs of each component

  • To compare the effectiveness of Full-SPARCS to care as usual to achieve HIV RNA suppression 6 months following correctional facility release
  • To assess determinants of implementation of Full-SPARCS
  • To assess the scalability through costing and cost effectiveness analysis of Full-SPARCS

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
27mo left

Started Nov 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Nov 2024Jul 2028

First Submitted

Initial submission to the registry

August 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 7, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

November 18, 2024

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3.7 years

First QC Date

August 31, 2023

Last Update Submit

February 9, 2026

Conditions

Keywords

Viral Load SuppressionPrisonTransitionCare continuityHIV

Outcome Measures

Primary Outcomes (1)

  • HIV RNA (viral load) suppression at 6 months

    HIV RNA suppression will be defined as a viral load \<1000 copies/mL. Participants without viral load data will be assumed to have a viral load \>1000 c/mL.

    6 months

Secondary Outcomes (4)

  • HIV RNA (viral load) suppression at 12 months

    12 months

  • Cost-effectiveness

    up to 12 months

  • Percentage of participants receiving ART at 6 months

    6 months

  • Percentage of participants receiving ART at 12 months

    12 months

Study Arms (2)

Care-as-usual (CAU) arm

NO INTERVENTION

Per DCS routine, at release, participants will receive a referral letter form the DCS health services and, in most cases, will be provided with a 28-day supply of ART.

Full -SPARCS intervention arm

EXPERIMENTAL

The Full-SPARCS component comprises one individual pre-release session, one individual post-release session, and 12 approximately every-other-week (approximately every two weeks) post-release group sessions extending six months post-release. The SPARCS curriculum is designed to build goal setting, prioritizing, and planning skills during the 12 sessions. During each Full-SPARCS session, participants will work with facilitators to set, review, and update personal goals using standardized goal-setting worksheets. These goal sheets will document participant objectives, action steps, timelines, and progress assessments.

Behavioral: Full-SPARCS Intervention

Interventions

Within 14 days of release, participants will have one-on-one contact with a facilitator to update locator information, continue rapport building, review disclosure plans, provide a reminder of SPARCS logistics, and assign or remind the participant to a SPARCS group based on their location of residence and timing of release (depending on whether this occurred pre-release). Each Full-SPARCS meeting lasts approximately 2 hours, and the sessions occur in a private space in a community venue (e.g., community centre or church).

Full -SPARCS intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Incarcerated at one of the participating study enrolment sites, awaiting trial (un-sentenced) and sentenced individuals.
  • Diagnosed with HIV and ART at the time of enrolment.
  • Anticipated release or trial date within three months of study enrolment.
  • Self-report expected to reside in an unrestricted environment within Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province and within proximity to one of the SPARCS intervention sites (i.e., within 20km, 45-minute travel time, or two local taxi minibus rides)
  • Willing to participate in study post-release follow-up activities and provide contact information for post-release follow-up.

You may not qualify if:

  • \<18 years of age.
  • Condition (severe cognitive dysfunction or mental illness) rendering the individual unable to provide informed consent.
  • Unable to provide informed consent to participate in the study.
  • Assessment by DCS health staff indicating that the individual requires a high intensity of care exceeding that which can be provided in a differentiated model of care setting.
  • Not released from the correctional facility during the period of intervention delivery.
  • Release to a region outside of Gauteng.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Aurum Institute - Head office

Johannesburg, Gauteng, 2193, South Africa

RECRUITING

Study Officials

  • Christopher Hoffmann

    Johns Hopkins School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christopher Hoffmann

CONTACT

Tonderai Mabuto

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigators will perform individual randomization blocked by the correctional facility. Study staff will open numbered envelopes with the allocation following enrolment. Participants will be randomized 1:1 to one of the study arms using sequential envelopes with study arm determination sealed inside. Randomization will be stratified by study site and by sex. The randomization lists for each site/sex combination will be generated through randomly permuted blocks of two, four, and six study assignments with an equal number of group assignments within each block. Study assignments will be masked to staff performing outcome assessments (in-person and telephonic interviews) and the investigators until all outcome data have been collected.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: This is a hybrid type 1 effectiveness-implementation study to compare care as usual with Full-SPARCS. The investigators will recruit participants from correctional facilities in the Department of Correctional Services (DCS) Gauteng Region, South Africa. Study activities for the intervention arm will be delivered in community venues near to where participants live in Tshwane District, Ekurhuleni District, and City of Johannesburg.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 7, 2023

Study Start

November 18, 2024

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

July 31, 2028

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations